Fauci Apologizes For UK V US Vaccine Comments: Not Better, Not Worse, Just Different

Top US Immunologist Says He Didn’t Mean To Accuse MHRA Of ‘Sloppiness’

The UK’s rapid authorization of the Pfizer/BioNTech COVID-19 vaccine has sparked a public debate over regulatory processes at some of the world’s key regulatory bodies.

Motion blurred racetrack,sunset scene
How quickly should you approve a coronavirus vaccine? • Source: Shutterstock

Dr Anthony Fauci, head of the US National Institute of Allergy and Infectious Diseases, has backtracked on his suggestion that the UK medicines regulator, the MHRA, “rushed through” its emergency authorization of the Pfizer Inc./BioNTech SE COVID-19 vaccine.

Fauci had claimed that the US Food and Drug Administration had the “gold standard” regulatory approach and that the MHRA...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from United Kingdom

More from Europe